Latest Share Chat

REMOVE ADS

Hemogenyx Pharmaceuticals Share News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

794.00 -35.50 (-4.44%)

Bid:

735.00

Ask:

794.00

Spread: 59.00 (8.027%)

Market Cap: £53.99m

Last checked at -

Intraday Hemogenyx Pharmaceuticals Share Chart

REMOVE ADS

Hemogenyx Pharmaceuticals News

EARNINGS: Titon half-year loss widens; Seplat quarterly profit down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...

Corporate News

TRADING UPDATES: GenIP partners with Cardinal IP; Orosur drill results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Corporate News

WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

Risers and Fallers

WINNERS & LOSERS: Tullow falls as oil down; Thungela swings to loss

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.

Risers and Fallers

EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company n...

SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukem...